Sri Lanka has decided to buy 6 million more Sputnik V vaccines, raising the total it plans to purchase from Russia to 13 million doses.
The government plans to inoculate 14 million people out of Sri Lanka's population of 22 million, and so far has approved the vaccines from Oxford-AstraZeneca, Sputnik V and China's Sinopharm.
Cabinet ministers approved the health minister's proposal for the purchase, Cabinet spokesman Keheliya Rambukwella said Tuesday.
It comes two weeks after the government said it would buy 7 million Sputnik V doses at a cost of $69.65 million.
Sri Lanka has vaccinated 903,000 people with the Oxford-AstraZeneca vaccine.
It will use donated Sinopharm doses to inoculate Chinese workers in Sri Lanka but will not administer the vaccine to Sri Lankans without World Health Organization approval.
It has received 1,264,000 doses of the Oxford-AstraZeneca vaccine and has said it would buy another 13.5 million.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU